A. Conway

发表

Hypothalamic‐pituitary adrenal function in end‐stage non‐alcoholic liver disease

David Handelsman, G. McCaughan, J. Mcdonald, 1993, Journal of gastroenterology and hepatology.

Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self‐reporting very good health: the healthy man study

David Handelsman, A. Zamojska, R. Mclachlan, 2012, Clinical endocrinology.

Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men.

David Handelsman, R. Desai, L. Kritharides, 2020, The Journal of clinical endocrinology and metabolism.

Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men.

David Handelsman, A. Aminorroaya, A. Conway, 2005, European journal of endocrinology.

Use, misuse and abuse of androgens

David Handelsman, B. Stuckey, J. Zajac, 2000, The Medical journal of Australia.

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

A. Keech, David Handelsman, B. Yeap, 2019, Trials.

Randomised controlled trial of whether erotic material is required for semen collection: impact of informed consent on outcome

David Handelsman, A. Conway, V. Jayadev, 2013, Andrology.

A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial

V. Gebski, A. Keech, A. Jenkins, 2019, Clinical trials.

Suppression of human spermatogenesis by testosterone implants.

David Handelsman, A. Conway, L. Boylan, 1992, The Journal of clinical endocrinology and metabolism.

Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study

David Handelsman, L. Kritharides, T. Chung, 2007, Clinical endocrinology.

Objective non-intrusive markers of sperm production and sexual activity.

David Handelsman, M. Jimenez, A. Conway, 2012, Asian journal of andrology.

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

H. Burger, David Handelsman, B. Yeap, 2016, The Medical journal of Australia.

Oestradiol enhances testosterone-induced suppression of human spermatogenesis.

David Handelsman, A. Conway, S. Wishart, 2000, Human reproduction.

Psychological and attitudinal profiles in donors for artificial insemination.

R. Jansen, David Handelsman, A. Conway, 1985, Fertility and sterility.

Long-term outcomes of elective human sperm cryostorage.

David Handelsman, A. Conway, L. Turner, 2001, Human reproduction.

Contraceptive efficacy of a depot progestin and androgen combination in men.

David Handelsman, Peter Y. Liu, M. Jimenez, 2003, The Journal of clinical endocrinology and metabolism.

Azoospermia after iodine-131 treatment for thyroid carcinoma.

David Handelsman, J. Turtle, A. Conway, 1980, British medical journal.

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men

David Handelsman, A. Conway, L. P. Ly, 2021, Endocrine connections.

Testosterone for Androgen Deficiency-Like Symptoms in Men Without Pathologic Hypogonadism: A Randomized, Placebo-Controlled Cross-Over with Masked Choice Extension Clinical Trial.

David Handelsman, A. Conway, L. Turner, 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation

David Handelsman, A. Conway, J. Grainger, 2014, The Journal of Steroid Biochemistry and Molecular Biology.

Complications of injectable testosterone undecanoate in routine clinical practice.

David Handelsman, A. Conway, L. Turner, 2015, European journal of endocrinology.

Sperm cryopreservation prior to gonadotoxic treatment: experience of a single academic centre over 4 decades.

David Handelsman, A. Conway, L. Vrga, 2019, Human reproduction.

HeterozygoteDetectionin CongenitalAdrenalHyperplasia

David Handelsman, J. Turtle, C. Howe, 2004 .

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

David Handelsman, C. Howe, A. Conway, 1996, The Journal of clinical endocrinology and metabolism.

Some ImprovementsIn Operation of the TechniconSMAC System

R. Grigg, David Handelsman, J. Turtle, 1980 .

Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.

David Handelsman, H. Baker, D. Rushford, 1999, Human reproduction.

Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.

H. Burger, N. Skakkebaek, A. Giwercman, 2003, Journal of andrology.

Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men.

David Handelsman, A. Conway, L. Turner, 1995, The Journal of clinical endocrinology and metabolism.

Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men.

V. Gebski, David Handelsman, Peter Y. Liu, 2002, Human reproduction.

Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome.

David Handelsman, M. Zacharin, Peter Y. Liu, 2009, The Journal of clinical endocrinology and metabolism.

Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume.

C. Minto, David Handelsman, C. Howe, 1997, The Journal of pharmacology and experimental therapeutics.

Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele.

David J. Handelsman, David Handelsman, J. Turtle, 1984, International journal of andrology.

Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections.

David Handelsman, J. Turtle, A. Conway, 1984, The New England journal of medicine.

Prevalence, testicular function and seminal parameters in men with sperm antibodies.

David Handelsman, J. Turtle, A. Conway, 1983, Clinical reproduction and fertility.

Randomized clinical trial of testosterone replacement therapy in hypogonadal men.

David Handelsman, C. Howe, A. Conway, 1988, International journal of andrology.

Pharmacokinetics and pharmacodynamics of testosterone pellets in man.

David Handelsman, A. Conway, L. Boylan, 1990, The Journal of clinical endocrinology and metabolism.

Pharmacokinetics and Pharmacodynamics of Nandrolone Esters in Oil Vehicle : Effects of Ester , Injection Site and Injection Volume 1

C. Minto, David Handelsman, C. Howe, 1997 .

Hypothalamic‐pituitary‐testicular function in end‐stage non‐alcoholic liver disease before and after liver transplantation

David Handelsman, G. McCaughan, S. Strasser, 1995, Clinical endocrinology.

Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin.

David Handelsman, D. Celermajer, Peter Y. Liu, 2003, European journal of endocrinology.

Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. I. Safety and effectiveness with outpatient therapy.

R. Jansen, I. Fraser, David Handelsman, 1987, Fertility and sterility.

Testicular Function and Glycemic Control in Diabetic Men A Controlled Study *

David Handelsman, D. Yue, J. Turtle, 2009, Andrologia.

Randomized cross‐over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men

David Handelsman, Peter Y. Liu, A. Conway, 2009, Clinical endocrinology.

Testosterone release rate and duration of action of testosterone pellet implants

David Handelsman, C. Howe, A. Conway, 2004, Clinical Endocrinology.

An analysis of testosterone implants for androgen replacement therapy

David Handelsman, C. Howe, A. Conway, 1997, Clinical endocrinology.

Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men

David J Handelsman, Ann Conway, David Handelsman, 2018, The Journal of clinical endocrinology and metabolism.

Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.

David Handelsman, A. Conway, G. Sartorius, 2010, Asian journal of andrology.

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.

Timothy D Handelsman, David Handelsman, R. Desai, 2019, Journal of the Endocrine Society.

Long-Term Effects of Dihydrotestosterone Treatment on Prostate Growth in Healthy, Middle-Aged Men Without Prostate Disease

M. Seibel, David Handelsman, D. T. Harwood, 2010, Annals of Internal Medicine.

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.

V. Gebski, A. Keech, A. Jenkins, 2021, The lancet. Diabetes & endocrinology.

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

V. Gebski, A. Keech, A. Jenkins, 2019, Diabetes, obesity & metabolism.

Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations

H. Burger, David Handelsman, B. Yeap, 2016, The Medical journal of Australia.

Blood testosterone threshold for androgen deficiency symptoms.

David Handelsman, A. Conway, S. Kelleher, 2004, The Journal of clinical endocrinology and metabolism.

Hormone treatment of gender identity disorder in a cohort of children and adolescents

David Handelsman, A. Conway, J. Hamblin, 2012, The Medical journal of Australia.

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

David Handelsman, D. Celermajer, M. Jimenez, 2001, The Journal of clinical endocrinology and metabolism.

Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responses.

R. Jansen, I. Fraser, David Handelsman, 1987, Fertility and sterility.

Effects of androgen deficiency and replacement on prostate zonal volumes

David Handelsman, A. Conway, B. Jin, 2001, Clinical endocrinology.

Pharmacokinetics of testosterone cream applied to scrotal skin

David Handelsman, R. Iyer, R. Desai, 2017, Andrology.

A randomised controlled clinical trial of antibiotic impregnation of testosterone pellet implants to reduce extrusion rate.

David Handelsman, A. Conway, S. Kelleher, 2002, European journal of endocrinology.

Andrology: Tolerability of intramuscular injections of testosterone ester in oil vehicle

David Handelsman, A. Conway, M. Mackey, 1995 .

Undecanoate in Routine Clinical Practice

David Handelsman, A. Conway, L. Turner, 2015 .

Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants

David Handelsman, A. Conway, S. Kelleher, 2001, Clinical endocrinology.

Detection of varicocele by radionuclide blood-pool scanning.

David Handelsman, G. Bautovich, A. Conway, 1980, Radiology.

Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial.

V. Gebski, A. Keech, A. Jenkins, 2019, Journal of clinical epidemiology.

Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.

David Handelsman, A. Conway, G. Sartorius, 2010, Asian journal of andrology.

Extrusion of testosterone pellets: a randomized controlled clinical study

David Handelsman, Conway, A. Conway, 1999, Clinical endocrinology.